MedPath

Effect of antioxidants in vitiligo

Phase 4
Completed
Conditions
Health Condition 1: L80- VitiligoHealth Condition 2: null- Vitiligo vulgaris
Registration Number
CTRI/2014/11/005223
Lead Sponsor
Shri Ram Murti Smarak Institute of Medical Sciences Bareilly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Clinically diagnosed case of vitiligo vulgaris

•They are not under a therapeutic regimen for previous two months and had not received drugs containing any anti-oxidants

•Patient having VIDA score >= +1

•Age >= 18 years

•Patients should be willing for Investigation, Treatment and Regular Follow up

Exclusion Criteria

•Age < 18 years

•Pregnancy or Lactation at present

•Hepatic, Renal, Lipid Profile Abnormalities

•Past/Present history of any type of Malignancy

•Patient unsure about attending treatment Schedule Regularly

•Previous H/o any Hypersensitivity Reaction to anti-oxidants

•Patients who fail to come for follow up after Initiation of therapy

•Patients with previous H/o Immunobullous disorders nad autoimmune diseases

•Patient is an alcoholic and smoker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oxidation stress indexTimepoint: Baseline and after 4 weeks
Secondary Outcome Measures
NameTimeMethod
Dermatology life quality indexTimepoint: Baseline and after 4 weeks;Activity and extent of vitiligo with the help of vitiligo disease activity scoreTimepoint: Baseline and after 4 weeks
© Copyright 2025. All Rights Reserved by MedPath